Soon, Sinovac Vaccines Can Be Used For Children Age 3 Years

Head of the Food and Drug Supervisory Agency (BPOM) Penny Lukito (Photo: Anom Prihantoro/Antara)

JAKARTA - The Indonesian Food and Drug Administration (BPOM) is waiting for complete safety data from the Sinovac vaccine to be given to the age group 3 years and over in Indonesia. "For Sinovac, we are waiting for more complete data to be given to children aged 3 years and over. above because that age is more vulnerable, so it requires more complete data for the security aspect," said Head of BPOM RI Penny K Lukito at the Commission IX Hearing Meeting (RDP) which was followed from the DPR RI YouTube channel in Jakarta, reported by Antara, Monday. , November 8. Penny said BPOM has issued an Emergency Use Authorization (EUA) for the use of Sinovac for the age group 6 years and over. According to Penny, a number of other vaccines that are also being prepared for groups of children in Indonesia are Sinopharm and Pfizer. This is also in the process for the Sinopharm vaccine and of course Pfizer has received EUA in its country through the Food and Drug Administration (FSA). DA) United States Agency," he said.

According to Penny, BPOM RI is waiting for the registration process for the two vaccines so that they can be used in Indonesia. "We are waiting to be registered at BPOM in the not too distant future when we get the data," he said. Penny added that currently there are 13 COVID-19 vaccines. 19 in Indonesia that have obtained EUA, including CoronaVac (Sinovac), Bio Farma COVID-19 Vaccine, AstraZeneca, Sinopharm, Moderna, Pfizer, Sputnik V, Janssen, Convidecia (CanSino) and Zifivax. Until now, there have been quite a number of around 13 COVID-19 vaccines from various platforms that have received EUA, this involves inactivated viruses, viral factors, mRNA and protein subunits," he said. represents all platforms in the world.